Dubin et al. [76] found that species belonging to the Bacteroidetes phylum conferred resistance to colitis that developed after anti-CTLA-4 antibody therapy, suggesting that expansion of these bacteria helps to prevent the development of ICI-induced colitis. This evidence concerns the gene CTLA4 and colitis.